DHRS1
Dehydrogenase/reductase SDR family member 1
Also known as: DHRS1_HUMAN, FLJ25430, MGC20204, SDR19C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96LJ7
- Gene
- DHRS1
- Ensembl
- ENSG00000157379
- Chromosome
- 14
- Canonical length
- 313 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome,Cytosol
OverviewNCBI Gene
This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family. The encoded enzyme contains a conserved catalytic domain and likely functions as an oxidoreductase. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
313 residues, UniProt reviewed canonical sequence.
>Q96LJ7|DHRS1
1 MAAPMNGQVC VVTGASRGIG RGIALQLCKA GATVYITGRH LDTLRVVAQE AQSLGGQCVP
61 VVCDSSQESE VRSLFEQVDR EQQGRLDVLV NNAYAGVQTI LNTRNKAFWE TPASMWDDIN
121 NVGLRGHYFC SVYGARLMVP AGQGLIVVIS SPGSLQYMFN VPYGVGKAAC DKLAADCAHE
181 LRRHGVSCVS LWPGIVQTEL LKEHMAKEEV LQDPVLKQFK SAFSSAETTE LSGKCVVALA
241 TDPNILSLSG KVLPSCDLAR RYGLRDVDGR PVQDYLSLSS VLSHVSGLGW LASYLPSFLR
301 VPKWIIALYT SKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DHRS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 70 nTPM
- liver: 59 nTPM
- skin: 42 nTPM
- cervix: 27 nTPM
- salivary gland: 27 nTPM
- vagina: 26 nTPM
Single-cell type
- late spermatids: 23 nCPM
- esophageal apical cells: 20 nCPM
- oligodendrocytes: 18 nCPM
- suprabasal keratinocytes: 17 nCPM
- microglia: 17 nCPM
- bergmann glia: 16 nCPM
Immune cell
- eosinophil: 18 nTPM
- basophil: 15 nTPM
- T-reg: 12 nTPM
- myeloid DC: 11 nTPM
- intermediate monocyte: 10 nTPM
- memory B-cell: 9.9 nTPM
Brain region
- white matter: 3.1 nTPM
- choroid plexus: 3 nTPM
- hypothalamus: 2.6 nTPM
- medulla oblongata: 2.6 nTPM
- cerebellum: 2.1 nTPM
- pons: 2.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
- carbonyl reductase (NADPH) activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- testosterone dehydrogenase (NADP+) activity
- estradiol 17-alpha-dehydrogenase [NAD(P)+] activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DHRS1 as an antibody target. Whether an autoantibody or antibody against DHRS1 could matter depends on whether native DHRS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DHRS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DHRS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...